| Primary |
| Colorectal Cancer |
57.3% |
| Prophylaxis |
11.1% |
| Squamous Cell Carcinoma |
6.1% |
| Colorectal Cancer Metastatic |
4.6% |
| Gastrooesophageal Cancer |
3.1% |
| Hypertension |
2.2% |
| Pain |
1.9% |
| Nausea |
1.6% |
| Oesophageal Adenocarcinoma |
1.3% |
| Rash |
1.3% |
| Non-small Cell Lung Cancer |
1.2% |
| Oesophageal Carcinoma |
1.2% |
| Constipation |
1.1% |
| Diabetes Mellitus |
1.1% |
| Gastric Cancer |
1.0% |
| Transitional Cell Carcinoma |
0.9% |
| Chemotherapy |
0.8% |
| Gastrooesophageal Reflux Disease |
0.8% |
| Prophylaxis Of Nausea And Vomiting |
0.8% |
| Insomnia |
0.7% |
|
| Interstitial Lung Disease |
8.4% |
| Vomiting |
8.3% |
| Pyrexia |
7.4% |
| Dermatitis Acneiform |
7.2% |
| Diarrhoea |
6.7% |
| Stomatitis |
6.7% |
| Neutropenia |
6.1% |
| Febrile Neutropenia |
5.8% |
| Pulmonary Embolism |
5.5% |
| Colorectal Cancer |
4.3% |
| Sepsis |
4.2% |
| Paronychia |
3.6% |
| Thrombocytopenia |
3.5% |
| White Blood Cell Count Decreased |
3.5% |
| Hypomagnesaemia |
3.4% |
| Rash |
3.3% |
| Nausea |
3.2% |
| Pneumonia |
3.1% |
| Weight Decreased |
2.9% |
| Mucosal Inflammation |
2.7% |
|
| Secondary |
| Colorectal Cancer |
59.8% |
| Prophylaxis |
18.5% |
| Colorectal Cancer Metastatic |
3.1% |
| Colon Cancer |
2.1% |
| Drug Use For Unknown Indication |
2.0% |
| Squamous Cell Carcinoma |
1.7% |
| Hypertension |
1.5% |
| Metastatic Neoplasm |
1.5% |
| Constipation |
1.3% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Prophylaxis Of Nausea And Vomiting |
1.0% |
| Adenocarcinoma Pancreas |
0.9% |
| Vomiting |
0.9% |
| Infection |
0.8% |
| Rash |
0.8% |
| Pain |
0.7% |
| Diabetes Mellitus |
0.6% |
| Colon Cancer Metastatic |
0.5% |
| Insomnia |
0.5% |
| Dry Skin |
0.5% |
|
| Dermatitis Acneiform |
18.6% |
| Stomatitis |
15.0% |
| Colorectal Cancer |
9.7% |
| Paronychia |
6.0% |
| Rash |
5.8% |
| Dry Skin |
4.9% |
| Interstitial Lung Disease |
4.8% |
| Hypomagnesaemia |
4.4% |
| Vomiting |
4.1% |
| Hypocalcaemia |
2.7% |
| Pulmonary Embolism |
2.7% |
| Pyrexia |
2.7% |
| White Blood Cell Count Decreased |
2.6% |
| Febrile Neutropenia |
2.4% |
| Pruritus |
2.4% |
| Thrombocytopenia |
2.4% |
| Diarrhoea |
2.2% |
| Malaise |
2.2% |
| Neutropenia |
2.2% |
| Infusion Related Reaction |
2.0% |
|
| Concomitant |
| Colorectal Cancer Metastatic |
15.2% |
| Rectal Cancer |
13.2% |
| Oesophageal Adenocarcinoma |
11.3% |
| Drug Use For Unknown Indication |
9.9% |
| Colon Cancer Metastatic |
8.6% |
| Pancreatic Carcinoma Metastatic |
5.3% |
| Rectal Cancer Metastatic |
5.3% |
| Colorectal Cancer |
4.6% |
| Neoplasm Malignant |
4.6% |
| Rectal Cancer Recurrent |
4.0% |
| Hypertension |
3.3% |
| Colon Cancer |
2.6% |
| Diabetes Mellitus |
2.6% |
| Prophylaxis |
2.0% |
| Adenocarcinoma Pancreas |
1.3% |
| Bile Duct Cancer |
1.3% |
| Nausea |
1.3% |
| Neuroendocrine Tumour |
1.3% |
| Pain |
1.3% |
| Adenocarcinoma |
0.7% |
|
| Vomiting |
16.7% |
| White Blood Cell Count Decreased |
10.0% |
| Hypomagnesaemia |
6.7% |
| Peripheral Motor Neuropathy |
6.7% |
| Sigmoiditis |
6.7% |
| Small Intestinal Haemorrhage |
6.7% |
| Abnormal Behaviour |
3.3% |
| Cardiac Arrest |
3.3% |
| Cardiac Failure Congestive |
3.3% |
| Diarrhoea |
3.3% |
| Disease Progression |
3.3% |
| Duodenal Ulcer Haemorrhage |
3.3% |
| Febrile Neutropenia |
3.3% |
| Hepatic Encephalopathy |
3.3% |
| Ischaemic Stroke |
3.3% |
| Metastases To Lung |
3.3% |
| Muscle Spasms |
3.3% |
| Neoplasm Progression |
3.3% |
| Neutrophil Count Decreased |
3.3% |
| Nodal Arrhythmia |
3.3% |
|
| Interacting |
| Colon Cancer Metastatic |
33.3% |
| Hyperlipidaemia |
16.7% |
| Hypertension |
16.7% |
| Malignant Ascites |
16.7% |
| Type 2 Diabetes Mellitus |
16.7% |
|
|
